KMCRIC

Synbiotic yogurt consumption by healthy adults and the elderly: the fate of bifidobacteria and LGG probiotic strain.

Granata M, Brandi G, Borsari A, Gasbarri R, Gioia DD.

Int J Food Sci Nutr.

2013

64(2)

162-8.

10.3109/09637486.2012.718742.

22946635

http://www.ncbi.nlm.nih.gov/pubmed/22946635

Adult
Bifidobacterium/growth & development*
Colon/microbiology
Colony Count, Microbial
Constipation/drug therapy*
Constipation/microbiology
Diet*
Double-Blind Method
Feces/microbiology
Female
Fructose/therapeutic use
Humans
Lactobacillus rhamnosus/growth & development*
Middle Aged
Oligosaccharides/therapeutic use*
Prebiotics
Probiotics/therapeutic use
Questionnaires
Reference Values
Synbiotics*
Yogurt*

fructooligosaccharides; Lactobacillus rhamnosus GG; prebiotics; constipation; synbiotic dietary supplements

프락토올리고당; 락토바실러스 람노서스; 프리바이오틱스; 변비; 신바이오틱 식이보충제

없음

Synbiotic dietary supplements are used to modulate the intestinal microbiota in adults; however, studies regarding elderly people are limited. The aim of this work is to determine the effect of regular consumption of yogurt containing Lactobacillus rhamnosus GG (LGG) and the fructooligosaccharide (FOS) Actilight(®) both in healthy adults and the elderly suffering from constipation. Yogurt was administered daily for 4 weeks; faecal samples were collected before starting, after 4-week administration and a 15-day wash out period, and analyzed for LGG and bifidobacteria counts. Constipation status in the elderly was recorded by a standardized questionnaire. Bifidobacteria did not increase in either groups; at the end of the intervention trial, LGG was detected in significantly different amount in the faeces of the elderly and adults, being higher in adults (95% vs. 30%). An increased evacuation number in the elderly was evidenced, probably due to the presence of FOS in yogurt.

영어